These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26385044)

  • 1. Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.
    Kim C; Kim BK; Lee SY; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2015 Sep; 170(3):591-7. PubMed ID: 26385044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.
    Vergallo R; Yonetsu T; Uemura S; Park SJ; Lee S; Kato K; Jia H; Abtahian F; Tian J; Hu S; Lee H; McNulty I; Prasad A; Yu B; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK
    Am J Cardiol; 2013 Nov; 112(9):1315-21. PubMed ID: 23891431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
    Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis.
    Lee SY; Shin DH; Mintz GS; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    EuroIntervention; 2013 Dec; 9(8):945-51. PubMed ID: 24384291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography.
    Yonetsu T; Kim JS; Kato K; Kim SJ; Xing L; Yeh RW; Sakhuja R; McNulty I; Lee H; Zhang S; Uemura S; Yu B; Kakuta T; Jang IK
    Am J Cardiol; 2012 Oct; 110(7):933-9. PubMed ID: 22727183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.
    Jang JY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2015 Oct; 242(2):553-9. PubMed ID: 26318104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis.
    Nakamura D; Attizzani GF; Toma C; Sheth T; Wang W; Soud M; Aoun R; Tummala R; Leygerman M; Fares A; Mehanna E; Nishino S; Fung A; Costa MA; Bezerra HG
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.
    Kang SJ; Mintz GS; Akasaka T; Park DW; Lee JY; Kim WJ; Lee SW; Kim YH; Whan Lee C; Park SW; Park SJ
    Circulation; 2011 Jun; 123(25):2954-63. PubMed ID: 21646494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry.
    Yonetsu T; Kato K; Kim SJ; Xing L; Jia H; McNulty I; Lee H; Zhang S; Uemura S; Jang Y; Kang SJ; Park SJ; Lee S; Yu B; Kakuta T; Jang IK
    Circ Cardiovasc Imaging; 2012 Sep; 5(5):660-6. PubMed ID: 22798521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
    Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.